Literature DB >> 12025834

Achieving RO resection for locally advanced gastric cancer: is it worth the risk of multiorgan resection?

Robert C G Martin1, David P Jaques, Murray F Brennan, Martin Karpeh.   

Abstract

BACKGROUND: In gastric adenocarcinoma, only complete resection (R0) translates into survival benefit. Given the potential for increased morbidity and mortality from multiple organ resection we asked the question as to whether extended (multiple organ) resection was justified for advanced gastric cancer. STUDY
DESIGN: From July 1985 to July 2000, 1,283 patients underwent gastric resection for adenocarcinoma at Memorial Sloan-Kettering Cancer Center, and were entered and followed in a prospectively recorded database. Four hundred eighteen patients (33%) underwent primary resection and had one or more organs resected in addition to the stomach. Eight hundred twenty-six patients (64%) underwent gastrectomy alone, with 39 patients (3%) not undergoing gastrectomy. Clinicopathologic, operative, and morbidity data were evaluated in this group. Complications were categorized by severity on a scale from 0 to 5, 0 being no complication to 5 being death. Chi-square analysis and the logistic regression method were used to compare and estimate factors significantly associated with having a complication.
RESULTS: Three hundred thirty-seven patients had a single additional organ resected, 63 had two organs, and 18 had three organs. Five hundred eighty complications occurred in 33% of patients (404 of 1,283). The perioperative mortality was 4% (48 patients). Logistic regression identified the number of organs resected, two or greater, to be predictive of complications (RR 2.0), as well as age greater than 70 years old (RR 1.57). When excluding minor complications (values 1 and 2), only the number of organs resected (RR 3.8) was a major factor for severe complications (values 3, 4, and 5).
CONCLUSIONS: Resection of two or more adjacent organs in advanced gastric adenocarcinoma is associated with a greater risk of developing a complication. The use of a graded surgical complication scale is needed for better reporting and comparison of complications. Achieving an R0 resection should still be considered the goal, even in locally advanced gastric cancer, but resection of additional organs should be performed judiciously.

Entities:  

Mesh:

Year:  2002        PMID: 12025834     DOI: 10.1016/s1072-7515(02)01116-x

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  41 in total

1.  Remnant growth rate after portal vein embolization is a good early predictor of post-hepatectomy liver failure.

Authors:  Universe Leung; Amber L Simpson; Raphael L C Araujo; Mithat Gönen; Conor McAuliffe; Michael I Miga; E Patricia Parada; Peter J Allen; Michael I D'Angelica; T Peter Kingham; Ronald P DeMatteo; Yuman Fong; William R Jarnagin
Journal:  J Am Coll Surg       Date:  2014-06-25       Impact factor: 6.113

2.  Multiorgan resection for gastric cancer: intraoperative and computed tomography assessment of locally advanced disease is inaccurate.

Authors:  Kari L Colen; Stuart G Marcus; Elliot Newman; Russell S Berman; Herman Yee; Spiros P Hiotis
Journal:  J Gastrointest Surg       Date:  2004-11       Impact factor: 3.452

3.  Robotic Liver Resection: A Case-Matched Comparison.

Authors:  T Peter Kingham; Universe Leung; Deborah Kuk; Mithat Gönen; Michael I D'Angelica; Peter J Allen; Ronald P DeMatteo; Vincent P Laudone; William R Jarnagin; Yuman Fong
Journal:  World J Surg       Date:  2016-06       Impact factor: 3.352

4.  Surgical treatment for gastric cancer in Turkish patients over age 70: early postoperative results and risk factors for mortality.

Authors:  Ilter Ozer; Erdal Birol Bostanci; Umit Koc; Kerem Karaman; Metin Ercan; Murat Ulas; Yusuf B Ozogul; Tahsin Dalgic; Musa Akoglu
Journal:  Langenbecks Arch Surg       Date:  2010-03-10       Impact factor: 3.445

5.  Predictive value of the Age-Adjusted Charlson Comorbidity Index on perioperative complications and survival in patients undergoing primary debulking surgery for advanced epithelial ovarian cancer.

Authors:  Rudy S Suidan; Mario M Leitao; Oliver Zivanovic; Ginger J Gardner; Kara C Long Roche; Yukio Sonoda; Douglas A Levine; Elizabeth L Jewell; Carol L Brown; Nadeem R Abu-Rustum; Mary E Charlson; Dennis S Chi
Journal:  Gynecol Oncol       Date:  2015-05-31       Impact factor: 5.482

6.  Reporting of adverse events in surgical trials: critical appraisal of current practice.

Authors:  Rachel Rosenthal; Henry Hoffmann; Kerry Dwan; Pierre-Alain Clavien; Heiner C Bucher
Journal:  World J Surg       Date:  2015-01       Impact factor: 3.352

7.  Prognostic Factors Affecting Survival After Multivisceral Resection in Patients with Clinical T4b Gastric Cancer.

Authors:  Kazuhito Mita; Hideto Ito; Toshio Katsube; Ayaka Tsuboi; Nobuyoshi Yamazaki; Hideki Asakawa; Takashi Hayashi; Keiichi Fujino
Journal:  J Gastrointest Surg       Date:  2017-09-22       Impact factor: 3.452

8.  Morbidity and mortality following multivisceral resections in complex hepatic and pancreatic surgery.

Authors:  Andrew McKay; Francis R Sutherland; Oliver F Bathe; Elijah Dixon
Journal:  J Gastrointest Surg       Date:  2007-08-21       Impact factor: 3.452

9.  A prospective, symptom related, outcomes analysis of 1022 palliative procedures for advanced cancer.

Authors:  Thomas J Miner; Murray F Brennan; David P Jaques
Journal:  Ann Surg       Date:  2004-10       Impact factor: 12.969

10.  Esophageal carcinoma histology affects perioperative morbidity following open esophagogastrectomy.

Authors:  Charles E Woodall; Ryan Duvall; Charles R Scoggins; Kelly M McMasters; Robert C G Martin
Journal:  J Oncol       Date:  2009-02-05       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.